Section Arrow
NTBL.NASDAQ
- Notable Labs Ltd
Quotes are at least 15-min delayed:2024/05/20 13:10 EDT
Last
 1.02
0 (0.00%)
Day High 
1.04 
Prev. Close
1.02 
1-M High
1.84 
Volume 
29.95K 
Bid
1.01
Ask
1.03
Day Low
1.01 
Open
1.01 
1-M Low
0.861 
Market Cap 
9.20M 
Currency USD 
P/E -- 
%Yield
10-SMA 1.14 
20-SMA 1.05 
50-SMA 1.32 
52-W High 392 
52-W Low 0.833 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.41/-0.74
Enterprise Value
10.72M
Balance Sheet
Book Value Per Share
1.68
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
310.00K
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1321+0.0286+27.63%-- 
NBYNovaBay Pharmaceuticals0.2075+0.0889+74.96%-- 
GTBPGT Biopharma8.1762+5.0562+162.06%-- 
JAGXJaguar Health0.16-0.0985-38.10%0.48PE
KTRAKintara Therapeutics0.1642+0.0212+14.83%-- 
Quotes are at least 15-min delayed:2024/05/20 13:10 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatmentand potentially enable fast-track therapeutic development in this patient population.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.